Synchronous vs Independent Reading of PSMA-PET and MRI in Prostate Cancer Diagnosis

What is it about?

This study aimed to investigate whether synchronous reading of multiparametric magnetic resonance imaging (mpMRI) and 68 Ga-PSMA-11 positron emission tomography (PET)/computed tomography (prostate-specific membrane antigen [PSMA-PET]) images can improve diagnostic performance and certainty compared to mpMRI/PSMA-PET reported independently and synthesized. The study found that synchronous reading of mpMRI/PSMA-PET increased sensitivity compared to mpMRI or PSMA-PET alone, but specificity was not improved. The study concluded that synthesizing independent PSMA-PET and mpMRI reports provided similar diagnostic performance to synchronous PSMA-PET/MRI reads, which would improve flexibility for urologists and patients and reduce healthcare system costs.

Featured Image

Why is it important?

This research is important because it evaluates the diagnostic performance and certainty of synchronous reading of mpMRI and PSMA-PET images in the diagnosis of prostate cancer. The findings can help inform clinical decision-making and potentially improve patient outcomes by reducing the number of unnecessary biopsies and identifying clinically significant prostate cancer earlier. Key Takeaways: 1. Synchronous reading of mpMRI/PSMA-PET increased sensitivity compared to mpMRI or PSMA-PET alone, although specificity was not improved. 2. No significant difference in diagnostic performance was noted between mpMRI/PSMA-PET read synchronously and mpMRI or PSMA-PET reported independently and then synthesized. 3. Most patients had concordant imaging, while others had discordant lesions only or a mixture of concordant and discordant lesions. 4. Synthesizing the results of independently read PSMA-PET and mpMRI reports provided similar diagnostic performance to synchronous PSMA-PET/MRI reads, offering greater flexibility for urologists in terms of referral patterns, reducing healthcare system costs, and improving efficiencies in prostate cancer diagnosis.